Prevalence of anti-HCV antibodies in chronic liver disease in the Czech Republic

被引：2
|
作者：
Stransky, J
Horejsova, M
Chlumska, A
Honzakova, E
Vandasova, J
Nemecek, V
机构：
[1] CHARLES UNIV,FAC MED 3,INTERNAL CLIN 2,PRAGUE 10034 10,CZECH REPUBLIC
[2] CHARLES UNIV,FAC MED 1,PATHOL INST 2,PRAGUE 12808 2,CZECH REPUBLIC
[3] BULOVKA FAC HOSP,REG HYG STN,DEPT VIROL,PRAGUE 18000 8,CZECH REPUBLIC
[4] NATL INST HLTH,PRAGUE 10034 10,CZECH REPUBLIC
来源：
INFECTION | 1997年 / 25卷 / 01期
关键词：
D O I：
10.1007/BF02113511
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [31] THE PRESENCE OF ANTI-HCV ANTIBODIES IN THE SERUM OF PATIENTS WITH CHRONIC ACTIVE HEPATITIS AND ANTINUCLEAR ANTIBODIES
    ROGET, M
    BUTI, M
    ESTEBAN, JI
    ESTEBAN, R
    GUARDIA, J
    HEPATOLOGY, 1990, 11 (02) : 333 - 334
  • [32] IGM ANTI-HCV CORE IN HCV-RNA POSITIVE SUBJECTS WITH AND WITHOUT CHRONIC LIVER-DISEASE
    CAPORASO, N
    MORISCO, F
    ROMANO, M
    PERSICO, M
    DESIO, I
    TUCCILLO, C
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1994, 26 (07): : 347 - 348
  • [33] Prevalence of anti-HCV antibodies in the personnel of the Antoine-Beclere Hospital.
    Maillard, MF
    Poynard, T
    Dubreuil, P
    Agostini, H
    Hautecoeur, B
    Pillot, J
    Chaput, JC
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1996, 20 (12): : 1053 - 1057
  • [34] Pathogenetic significance of neutralizing anti-HCV antibodies in acute and chronic hepatitis C virus (HCV) infection of chimpanzees treated with hyperimmune anti-HCV (Civacir™)
    Krawczynski, K
    Bartosch, B
    Meunier, JC
    Basham, L
    Culver, D
    Lavillette, D
    Kamili, S
    Cosset, FL
    Fattom, A
    HEPATOLOGY, 2005, 42 (04) : 277A - 277A
  • [35] Prevalence of anti-HCV antibodies in the congolese population: A study on 985 blood donors
    Elenga, JPO
    Atanda, H
    Koffi, G
    Sangare, A
    Lomani, BLD
    MEDECINE ET MALADIES INFECTIEUSES, 1998, 28 (10): : 673 - +
  • [36] Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco
    Sekkat, Souad
    Kamal, Nabiha
    Benali, Bennaceur
    Fellah, Hassan
    Amazian, Kamelia
    Bourquia, Amal
    El Kholti, Abdeljalil
    Benslimane, Abdellah
    NEPHROLOGIE & THERAPEUTIQUE, 2008, 4 (02): : 105 - 110
  • [37] INTERFERON THERAPY OF CRYPTOGENIC CHRONIC ACTIVE LIVER-DISEASE AND ITS RELATIONSHIP TO ANTI-HCV
    DIODATI, G
    BONETTI, P
    TAGGER, A
    ALBERTI, A
    REALDI, G
    RUOL, A
    ARCHIVES OF VIROLOGY, 1992, : 299 - 303
  • [38] Anti-HCV antibodies: A battle for breadth and potency
    Jamali, Elham
    Quadeer, Ahmed Abdul
    Tedla, Nicodemus
    McKay, Matthew R.
    Lloyd, Andrew
    Walker, Melanie R.
    Bull, Rowena A.
    ANTIVIRAL RESEARCH, 2025, 238
  • [39] Clinical manifestations of HBsAg and anti-HCV negative chronic liver disease in Nagasaki Prefecture, Japan
    Omagari, K
    Komatsu, K
    Kato, Y
    Nakata, K
    Kusumoto, Y
    Mori, I
    Furukawa, R
    Tanioka, H
    Tajima, H
    Koga, M
    Yano, M
    INTERNAL MEDICINE, 1996, 35 (08) : 600 - 604
  • [40] ELISA KITS FOR SCREENING ANTI-HCV ANTIBODIES
    JANOT, C
    BARIN, F
    BOUDART, D
    COTTE, C
    COUROUCE, AM
    ELGHOUZZI, MH
    JULLIEN, AM
    LEMAIRE, JM
    MAISONNEUVE, P
    MANIEZ, M
    MATTLINGER, B
    MENAULT, M
    MONCHARMONT, P
    MOUILLOT, L
    NORTH, ML
    OPOLON, P
    PIQUET, Y
    SMILOVICI, W
    TREPO, C
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1994, 1 (01) : 47 - 48
12345